The emerging AI x TechBio stack (120 companies mapped) (opens in new tab)

In Part I of our AI x TechBio series we drew on 40+ interviews with senior pharma leaders and startup founders to break down what “good” looks like across (1) proprietary data, (2) algorithms, and (3) lab-in-the-loop infrastructure and agentic AI workflows, illustrated with case studies spanning new architectures like JEPA to curiosity-driven agentic AI...